1 I. Tengiz, E. Ercan, C. Sekuri, E. Aliyev, S. Saygı, S. Guneri, M. Akin ve I. Nalbantgil, “The relationship between severity of coronary artery disease and endothelial dysfunction,” XXV. st Congress of the European Society of Cardiology, Munich, Germany, 2004
2 I. Tengiz, E. Aliyev, E. Ercan, I. Altuglu, C. Sekuri, S. Saygı, M. Akin ve I. Nalbantgil, “Elevated levels of matrix metalloproteinase-3 in coronary aneurysmatic patients,” XVI. Annual Meeting Mediterranean Association of Cardiology and Cardiac Surgery, Bodrum, Turkey, 2004, Sözlü sunum.
3 I. Tengiz, E. Aliyev, E. Ercan, F. Sahin, C. Sekuri, S. Saygı, M. Akin ve I. Nalbantgil, “Presence of factors active platelet agregation in mitral stenotic patients’ plasma,” XVI. Annual Meeting Mediterranean Association of Cardiology and Cardiac Surgery, Bodrum, Turkey, 2004, Sözlü sunum.
4 I. Tengiz, H. Bozdemir, E. Ercan, E. Aliyev, C. Sekuri, I. Altuglu, A. Akilli ve M. Akin, “The relationship between level of cell adhesion molecules and extent of coronary artery disease in patients with unstable angina pectoris,” XVI. Annual Meeting Mediterranean Association of Cardiology and Cardiac Surgery, Bodrum, Turkey, 2004, Sözlü sunum.
5 I. Tengiz, E. Aliyev, E. Ercan, C. Duman, C. Sekuri, S. Saygı, M. Akin ve I. Nalbantgil, “Decreased plasminogen activatior inhibitor-1 levels in coronary artery aneurysmatic patients,” XVI. Annual Meeting Mediterranean Association of Cardiology and Cardiac Surgery, Bodrum, Turkey, 2004
6 I. Tengiz, E. Aliyev, E. Ercan, C. Sekuri, S. Saygı, A. Akilli, M. Akin ve I. Nalbantgil, “Inflammation and electrocardiographic changes in patients with unstable angina pectoris,” XVI. Annual Meeting Mediterranean Association of Cardiology and Cardiac Surgery, Bodrum, Turkey, 2004
7 E. Aliyev, I. Tengiz, E. Ercan, C. Sekuri, S. Saygi, I. Nalbantgil ve M. Akin, “The relationship between levels of plasma homocysteine and prevalence of coronary artery disease in diabetic patients,” XVI. Annual Meeting Mediterranean Association of Cardiology and Cardiac Surgery, Bodrum, Turkey, 2004
8 I. Tengiz, G. S. Tamer, E. Ercan, E. Alioglu, U. O. Turk, C. Duman, S. Saygı ve I. Nalbantgil, “Helicobacter pylori seropositivity in patients with acute or chronic coronary artery disease,” 6th International Congress on Coronary Artery Disease-From Prevention to Intervention, Istanbul,Turkey, 2005
9 I. Tengiz, G. S. Tamer, E. Ercan, E. Alioglu, U. O. Turk, C. Duman, S. Erdogan ve I. Nalbantgil, “The correlation between levels of helicobacter pylori IgG and extent of angiographic coronary atherosclerosis,” 6th International Congress on Coronary Artery Disease-From Prevention to Intervention, Istanbul, Turkey, 2005
10 I. Tengiz, E. Ercan, E. Alioglu, U. O. Turk, C. Duman, C. Sekuri, S. F. Cam, A. Sazci ve I. Nalbantgil, “The influence of diabetes mellitus and hyperhomocysteinemia on carotid intima-media thickness in patients with coronary artery disease,” 6th International Congress on Coronary Artery Disease-From Prevention to Intervention, Istanbul, Turkey, 2005
11 I. Tengiz, E. Ercan, E. Alioglu, U. O. Turk, C. Sekuri, S. F. Cam, E. Ergul, G. Akpinar ve A. Sazci, “The variants of atherosclerosis-related genes and the extent of coronary artery disease in Turkish population,” 6th International Congress on Coronary Artery Disease-From Prevention to Intervention, Istanbul, Turkey, 2005
12 E. Ercan, I. Tengiz, E. Alioglu, U. Turk, G. Sonmez Tamer, C. Duman, H. Gocer ve M. Akin, “Balloon angioplasty induced myocardial ischemia increases erythropoietin in patients with stable angina pectoris,” 6th International Congress on Coronary Artery Disease-From Prevention to Intervention, Istanbul, Turkey, 2005, Sözlü sunum.
13 E. Ercan, C. Duman, G. Sonmez, I. Tengiz, E. Alioglu, U. Turk, C. Sekuri ve S. Cam, “Decreased erythropoietin levels after cardiac ischemia”, World Congress of Cardiology 2006, Barcelona, Spain, 2006
14 H. Duygu, U. Turk, B. Kirilmaz, E. Aliyev, C. Turkoglu, “Statins might improve coronary blood flow after percutaneous coronary intervention” 77th Congress of the European Atherosclerosis Society 2008, Istanbul, Turkey.
15 F.S. Cam, C. Sekuri, A. Sagcan, E. Ercan, I. Tengiz, E. Alioglu, A. Berdeli, “Lack of association between MCP-1 gene polymorphism (-2518G/A) and premature coronary artery disease” 77th Congress of the European Atherosclerosis Society 2008, Istanbul, Turkey.
16 E. Alioglu, E. Ercan, I. Tengiz, U. Turk, M. Ergun, S. Akgoz, C. Islegen, A. Berdeli, “The influence of alpha-adducin gene polymorphism on response of blood pressure to exercise in patients with hypertension” Congress of the European Society of Cardiology, Munich, Germany, 2008
17 U.O. Turk, E. Alioglu, B. Kirilmaz, G.S. Tamer, I. Tengiz, N. Tuzun, E. Ercan, ‘‘Adiponectin levels is strongly associated with NT-Brain Natriuretic Peptide levels, LV diameters and ejection fraction in patients with heart failure’’ Congress of the European Society of Cardiology, Barcelona, Spain, 2009
18 E. Alioglu, U.O. Turk, E. Ercan, G.S. Tamer, I. Tengiz, B. Kirilmaz,, S Saygi, N. Tuzun, ‘‘Effect of N-acetylcysteine on serum creatinine and cystatin C levels after cardiovascular procedures’’ Congress of the European Society of Cardiology, Barcelona, Spain, 2009
19 N Tuzun, M Ergun, E. Alioglu, U.O. Turk, I. Tengiz, S Saygi, E. Ercan, C Islegen, ‘‘Myocardial performance index in sprinters and endurance athletes’’ Congress of the European Society of Cardiology, Barcelona, Spain, 2009
20 E. Ertugrul, I. Tengiz, M. Zoghi, B. Kirilmaz, U. Turk, E. Alioglu, S. Saygi, R. Onder. A New Public Health Policy Initiative to Reduce Sodium Consumption. The 23rd Scientific Meeting Of The International Society Of Hypertension, Global Cardiovascular Risk Reduction, Vancouver, Canada 2010, p: . 8
21 S. Saygi, U. Onsel Turk, N. Tuzun, B. Kirilmaz, E. Alioglu. A Staphylococcus aureus endocarditis appeared with skin manifestations. Congress of European Society of Cardiology Cardiologists of tomorrow, clinical cases, Stockholm, Sweden 2010, p: . 36
22 S. Saygi, E. Alioglu, U.Onsel Turk, N. Tuzun, B. Kirilmaz. Thrombotic occlusion of a left main coronary artery in a patient with prosthetic mitral valve. Congress of European Society of CardiologyCardiologists of tomorrow, clinical cases, Stockholm, Sweden 2010, p: . 36